Provided by Tiger Trade Technology Pte. Ltd.

Ardelyx

3.38
-0.0100-0.29%
Post-market: 3.380.00000.00%18:35 EDT
Volume:4.23M
Turnover:14.38M
Market Cap:842.25M
PE:-14.86
High:3.50
Open:3.44
Low:3.34
Close:3.39
52wk High:8.40
52wk Low:3.34
Shares:249.19M
Float Shares:219.00M
Volume Ratio:0.86
T/O Rate:1.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2275
EPS(LYR):-0.2556
ROE:-38.61%
ROA:-4.25%
PB:5.65
PE(LYR):-13.23

Loading ...

Ardelyx Q1 EPS USD -0.15

THOMSON REUTERS
·
May 01

Ardelyx Inc: Reiterates Its Full-Year 2026 Revenue Guidance

THOMSON REUTERS
·
May 01

Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
May 01

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Apr 30

Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF’s Spring Clinical Meetings

GlobeNewswire
·
Apr 27

Ardelyx (ARDX) Receives a Buy from Piper Sandler

TIPRANKS
·
Apr 24

Earning Preview: Ardelyx this quarter’s revenue is expected to increase by 20.17%, and institutional views are bullish

Earnings Agent
·
Apr 24

Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026

GlobeNewswire
·
Apr 23

Ardelyx files Form 3 for Chief Legal Officer Felecia Ettenberg

Reuters
·
Apr 23

Ardelyx names Felecia Ettenberg chief legal officer, replacing retiring Elizabeth Grammer

Reuters
·
Apr 20

Press Release: Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer

Dow Jones
·
Apr 20

Ardelyx CEO Michael Raab sells 41,668 shares for $261,956.86

Reuters
·
Apr 18

Ardelyx schedules quarterly results conference call and webcast

Reuters
·
Apr 16

Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026

GlobeNewswire
·
Apr 16

Ardelyx files beneficial ownership Form 3 for Chief Medical Officer Rajani Dinavahi

Reuters
·
Apr 04

Press Release: Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx

Dow Jones
·
Apr 01